all report title image
  • Published On : Jan 2023
  • Code : CMI2535
  • Industry : Advanced Materials
  • Pages : 130
  • Formats :

Biomaterials have gained tremendous attention in tissue engineering and regenerative medicine applications attributing to their ability to enhance functional tissue regeneration. Biomaterial can be categories into natural biomaterials and synthetic biomaterials. Natural biomaterials offer various advantages over synthetic biomaterials such as they already have binding sites for cells and adhesion molecules so the biocompatibility is not a major issue. On account of advantages offered, the demand for natural biomaterials is projected to upsurge over the forecast period.

Global natural biomaterials market was valued at US$ 75.07 Billion in 2021 in terms of revenue, exhibiting a CAGR of 14.45% during the forecast period (2022 to 2030).

Drivers

Growing substantially over the forecast period, owing to rising prevalence of conditions such as osteoarthritis, rheumatoid arthritis, and sports injuries. Moreover, factors such as rising prevalence of cardiovascular diseases, increasing demand for plastics surgeries, growing cancer incidence are playing major role in fueling growth of the natural biomaterials market.

Naturally derived biomaterials is classified into many groups including polysaccharide-based biomaterials (chitin/chitosan, cellulose, glucose, etc.), protein-based biomaterials (gelatin, collagen, silk, etc.), and de-cellularized tissue-derived biomaterials (blood vessels, liver, heart valves, etc.). Natural biomaterials are preferred over synthetic biomaterials for restoring or replacing structure and for functioning of damaged tissues or organs attributing to their ability to support migration, cell adhesion, differentiation, and proliferation. The three main applications of natural biomaterials in medical are drug delivery system, tissue engineering, and wound management applications.

The COVID-19 pandemic has had a huge impact on the world's population. Rapid development of prophylactic vaccinations and patient treatment methods increased demand for innovative products. Engineered biomaterials were utilized to stimulate certain immune system responses & increase efficacy. Aesthetic operations, including breast augmentation and lipoplasty, and also non-essential dental procedures, have been delayed due to the COVID-19 outbreak. Furthermore, the pandemic had a substantial impact on the U.S., China, Japan, and European countries from March to June of 2020. The bulk of these countries are major biomaterials manufacturers, and the outbreak and global lockdowns have resulted in a drop in sales. This has a negative impact on the biomaterials industry. However, the industry recovered within the next two years as research into the development of a rapid COVID-19 detection test based on gold nanoparticles is expected to drive revenue growth of the market.

Figure 1. Global Natural Biomaterials Market Value Share (%), By Region, 2021

Natural Biomaterials  | Coherent Market Insights

Market Restraints

Lack of reimbursement policies and inadequate supply of natural tissues are estimated to restrain the global natural biomaterials market growth. Difficulties relating to biocompatibility of biomaterials with living tissues are also projected to hamper the market in the near future.

CMI table icon

Natural Biomaterials Market Report Coverage

Report Coverage Details
Base Year: 2021 Market Size in 2021: US$ 75.07 Bn 
Historical Data for: 2017-2020 Estimated Year: 2022
Forecast Period 2022 to 2030 CAGR: 14.45% Forecast Period: 2022-2030
Geographies covered:
  • By Region: North America, Latin America, Europe, Asia Pacific, Middle East & Africa
Segments covered:
  • By Product Type: Hyaluronic Acid, Collagen, Gelatin, Fibrin, Cellulose, Chitin/chitosan, Others
  • By Application: Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Neurology, Neurological Disorders/Central Nervous Systems, Tissue Engineering, Ophthalmology, Others
Companies covered:

BASF SE, Biomet, Inc., Invibio Ltd., Mimetis Biomaterials, Royal DSM, Corbion N.V., Botiss Biomaterials GmbH, and Medtronic, Inc.

Growth Drivers:
  • Rising prevalence of conditions such as osteoarthritis, rheumatoid arthritis, and sports injuries
Restraints & Challenges:
  • Lack of reimbursement policies
  • Inadequate supply of natural tissues

Market Trends

Various development in the gene therapy and medicine industries are considered as one of the major driving factors for the natural biomaterials market in terms of volume and value during the forecasted period.  Advancement in technology and manufacturing process in medical industry with developed equipment in developed and emerging countries are boosting the market growth. Accumulative aged residents have been facing to several chronic diseases is another factor rushing demand in the global natural biomaterials market. Additionally, budding application of biomaterial in numerous advanced medical technologies like plastic surgery, tissue engineering, drug delivery devices, are going to open numerous opportunities for the market growth. On the other hand, use of the targeted material for tissue designing and rising cases of knee and hip replacement surgeries application is further measured as a foremost growth factor.

Figure 2. Global Natural Biomaterials Market Value Share (%), By Application, 2021

Natural Biomaterials  | Coherent Market Insights

Recent Developments

  • In June 2022, DuPont, a global leader in innovation through technology-based materials and solutions, completed the previously announced sale of its Biomaterials business unit to the Huafon Group for approximately US$ 240 million.
  • In March 2022, Evonik Industries, a stock-listed German specialty chemicals company commercially launched EUDRATEC Fasteric used for enteric fortification and prompt release in the upper smaller intestine, which is a platform of oral drug delivery technology directly over the released target. This product development improved the biocompatibility, safety, and performance of implantable products used by medical device customers and further strengthened Evonik’s growth.

Competitive Section

Major players operating in the global natural biomaterials market include BASF SE, Biomet, Inc., Invibio Ltd., Mimetis Biomaterials, Royal DSM, Corbion N.V., Botiss Biomaterials GmbH, and Medtronic, Inc. 

Biomaterials are regarded as non-drug material, which is used for enhancing or replacing and treating any tissue, organ or function in an organism. The definition of biomaterial was reframed as a non-drug substance, which is suitable for inclusions in systems, replacing or augmenting the function of body tissue or organ. This materials can be synthetic or natural, non-living or living, and are made of multiple components that interact with biological system. They are compatible to be used in place of living tissues in organisms.

Market Dynamics

Increase in investment in research and development of precision medicine and molecular biology is the key factor augmenting the market. Rise in geriatric population that is prone to various chronic diseases is another factor boosting the demand for natural biomaterials. Growth in usage of biomaterial science in various advanced medical technologies, such as drug delivery devices, plastic surgery, tissue engineering, and other medical implants, is expected to propel the market growth in the near future.

Biomaterials are widely used in drug delivery and are biodegradable so that they can disappear from organism after the completion of their function. These can be used in medical applications as replacement to bones, cartilage regeneration during an orthopedic surgery, collagen membrane and regenerative dentistry. Advancements in tissue designing and increase in number of knee and hip replacement surgeries have created lucrative opportunities for the global natural biomaterials market growth. Extensive research and development activities supported by key players to develop advanced biomaterial products is also anticipated to boost the market growth.

Key features of the study:

  • This report provides in-depth analysis of global natural biomaterials market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year.
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global natural biomaterials market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include, BASF SE, Biomet, Inc., Invibio Ltd., Mimetis Biomaterials, Royal DSM, Corbion N.V., Botiss Biomaterials GmbH, and Medtronic, Inc.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision regarding future products launches, technology up gradation, market expansion, and marketing tactics
  • The global natural biomaterials market report caters to various stakeholders in this industry including investors, suppliers, natural biomaterials manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global natural biomaterials market

Detailed Segmentation:

  • Global Natural Biomaterials Market, By Product Type:
    • Hyaluronic Acid
    • Collagen
    • Gelatin
    • Fibrin
    • Cellulose
    • Chitin/chitosan
    • Others
  • Global Natural Biomaterials Market, By Application:
    • Cardiovascular
    • Orthopedic
    • Dental
    • Plastic Surgery
    • Wound Healing
    • Neurology
    • Neurological Disorders/Central Nervous Systems
    • Tissue Engineering
    • Ophthalmology
    • Others 
  •  Global Natural Biomaterials Market, By Region:
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
    • Latin America
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
    • Asia Pacific
      • China
      • India
      • Japan
      • ASEAN
      • South Korea 
      • Australia
      • Rest of Asia Pacific
    • Middle East & Africa
      • Middle East
      • Africa
  • Company Profile
    • BASF SE
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Future Plans
    • Biomet, Inc.
    • Berkeley Advanced Biomaterials, Inc. (BAB)
    • DSM Biomedical
    • Evonik Industries AG
    • Bayer AG
    • Invibio Ltd.
    • Botiss Biomaterials GmbH
    • Medtronic, Inc.

“*” marked represents similar segmentation in other categories in the respective section

Frequently Asked Questions

Global natural biomaterials market was valued at around US$ 75.07 Billion in 2021.
Rising prevalence of conditions such as osteoarthritis, rheumatoid arthritis, and sports injuries one of the major factors that is expected to propel growth of the market over the forecast period.
Various development in the gene therapy and medicine industries are some of the main trends in market.
Lack of reimbursement policies and inadequate supply of natural tissues are estimated to restrain the market.
Major players operating in the market include BASF SE, Biomet, Inc., Invibio Ltd., Mimetis Biomaterials, Royal DSM, Corbion N.V., Botiss Biomaterials GmbH, and Medtronic, Inc.
The market is estimated to grow at around 14.45% CAGR in the forecast period (2022-2030).

Related Reports

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo